mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Marginal read alignment evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
| * | NZ_CP009273 | 822,957 | 0 | A | G | 61.1% | 4.5 / 12.2 | 18 | L494P (CTC→CCC) | ybhF | ATP‑binding cassette domain‑containing protein |
| * | NZ_CP009273 | 2,778,686 | 0 | T | G | 61.1% | 7.0 / 17.0 | 18 | intergenic (‑316/+435) | BW25113_RS25705/BW25113_RS13825 | DUF5507 domain‑containing protein/tRNA‑Ile |
| * | NZ_CP009273 | 2,371,314 | 0 | G | A | 57.9% | ‑5.2 / 14.4 | 19 | F475F (TTC→TTT) | menD | 2‑succinyl‑5‑enolpyruvyl‑6‑hydroxy‑3‑ cyclohexene‑1‑carboxylic‑acid synthase |
| * | NZ_CP009273 | 3,964,452 | 0 | T | G | 56.2% | 6.1 / 13.4 | 16 | G320G (GGT→GGG) | wecB | UDP‑N‑acetylglucosamine 2‑epimerase (non‑hydrolyzing) |
| * | NZ_CP009273 | 536,014 | 0 | T | G | 55.6% | 9.5 / 20.2 | 18 | intergenic (+50/‑7) | allB/ybbY | allantoinase AllB/uracil/xanthine transporter |
| * | NZ_CP009273 | 1,976,010 | 0 | C | A | 55.6% | ‑0.8 / 12.5 | 9 | intergenic (‑142/+25) | otsB/araH | trehalose‑phosphatase/arabinose ABC transporter permease AraH |
| * | NZ_CP009273 | 3,387,038 | 0 | A | T | 55.6% | 1.3 / 18.8 | 18 | S860R (AGT→AGA) | yhdP | AsmA2 domain‑containing protein YhdP |
| * | NZ_CP009273 | 4,594,161 | 0 | C | T | 55.0% | ‑2.6 / 15.0 | 20 | S62F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 3,214,112 | 0 | T | A | 54.5% | 6.1 / 13.1 | 11 | N420K (AAT→AAA) | ygjG | putrescine aminotransferase |
| * | NZ_CP009273 | 1,570,334 | 0 | C | A | 53.8% | 7.1 / 20.3 | 13 | D515Y (GAT→TAT) | yddB | TonB‑dependent receptor plug domain‑containing protein |
| * | NZ_CP009273 | 2,141,218 | 0 | C | A | 53.8% | 5.7 / 16.2 | 13 | P22T (CCG→ACG) | yegD | molecular chaperone |
| * | NZ_CP009273 | 892,811 | 0 | T | G | 52.9% | 10.5 / 17.4 | 17 | V91G (GTG→GGG) | potI | putrescine ABC transporter permease PotI |
| * | NZ_CP009273 | 3,964,457 | 0 | T | G | 52.9% | 18.3 / 20.1 | 17 | V322G (GTG→GGG) | wecB | UDP‑N‑acetylglucosamine 2‑epimerase (non‑hydrolyzing) |
| * | NZ_CP009273 | 333,785 | 0 | G | T | 52.6% | 20.7 / 36.0 | 19 | V433L (GTG→TTG) | fdrA | acyl‑CoA synthetase FdrA |
| * | NZ_CP009273 | 2,860,603 | 0 | A | T | 52.6% | ‑1.7 / 12.8 | 20 | V103E (GTA→GAA) | rpoS | RNA polymerase sigma factor RpoS |
| * | NZ_CP009273 | 2,331,202 | 0 | A | C | 52.4% | 20.9 / 26.3 | 21 | G566G (GGT→GGG) | gyrA | DNA topoisomerase (ATP‑hydrolyzing) subunit A |
| * | NZ_CP009273 | 4,594,167 | 0 | C | T | 50.0% | 0.2 / 12.0 | 20 | S64F (TCT→TTT) | bglJ | DNA‑binding transcriptional activator BglJ |
| * | NZ_CP009273 | 2,241,903 | 0 | C | A | 44.0% | 38.9 / 14.1 | 25 | V37F (GTT→TTT) | lysP | lysine‑specific permease |